Rocket Lab's CFO and Grab's COO each sold shares on September 2 under pre-set 10b5-1 plans

Two executives at very differently-positioned companies sold stock on the same day. RKLB chief financial officer Adam Spice exercised options at $1.09 a share and immediately sold 140,157 shares at $62.63 on September 2, 2026, raising approximately $8.8 million through a pre-planned Rule 10b5-1 arrangement. He retains about 1.4 million shares . The same day, Grab chief operating officer Alexander Hungate sold roughly 145,000 Class A ordinary shares at a weighted average $3.48, for about $506,000, under a 10b5-1 plan adopted in March 2026. That represented 2% of his direct equity stake, and he still holds over 6.1 million shares .

Pre-arranged plans are the important qualifier on both. A 10b5-1 sale is scheduled months in advance precisely so that it cannot be timed on inside knowledge, and neither disposal is large relative to the position it came from. What the two trades do usefully illustrate is how far apart the underlying setups are.

Rocket Lab's is the more interesting of the two, because the headline return and the chart disagree. The stock has returned 28% over one year, helped by 62% year-over-year Q2 sales growth and a record 90-launch backlog , yet it trades about 58% below the highs it set earlier this year, part of a sector-wide de-rating in space-economy names after SpaceX's IPO this summer . The business mix explains some of the caution: the space systems segment generated $189.5 million last quarter against $44.6 million from launch, the Neutron rocket's first flight has slipped from 2024 to the start of 2027, the company has never posted a profit, and at $769 million of trailing revenue the shares carry a price-to-sales ratio around 48 . SentiSense data shows the analyst mean target at $111.00 across 18 analysts against a $64.26 share price, a 72% gap that is itself a statement about how much of the thesis rests on Neutron and the pending Iridium Communications acquisition.

Grab's picture is the inverse: operationally steady, poorly received. The company reported 22% year-over-year Q2 sales growth, yet the shares are down 28% over twelve months and trade near a 52-week low at $3.42, a decline attributed to macroeconomic pressure, rotation out of emerging markets, and Uber chief executive Dara Khosrowshahi's departure from Grab's board . Neither sale should be read as a verdict on either business. The things worth watching are Neutron's slip risk into 2027, whether Rocket Lab's space systems revenue keeps outrunning launch, and whether Grab's growth rate eventually forces a re-rating.

Related Stocks

• RKLB
• UBER